Provided by Tiger Trade Technology Pte. Ltd.

CITIUS ONCOLOGY INC

1.13
+0.02001.80%
Post-market: 1.130.00000.00%19:56 EST
Volume:113.39K
Turnover:127.21K
Market Cap:99.75M
PE:-3.34
High:1.15
Open:1.10
Low:1.08
Close:1.11
52wk High:6.19
52wk Low:0.5506
Shares:88.28M
Float Shares:12.32M
Volume Ratio:0.69
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3380
EPS(LYR):-0.3380
ROE:-54.42%
ROA:-15.87%
PB:2.22
PE(LYR):-3.34

Loading ...

Company Profile

Company Name:
CITIUS ONCOLOGY INC
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
11 Commerce Drive,First Floor,Cranford,New Jersey,United States
Zip Code:
07016
Fax:
- -
Introduction:
TenX Keane Acquisition focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was incorporated in 2021 and is based in New York, New York.

Directors

Name
Position
Leonard Mazur
Chairman and Chief Executive Officer and Director
Myron Holubiak
Director and Secretary
Carol Webb
Director
Dennis M. McGrath
Director
Eugene Holuka
Director
Joel Mayersohn
Director
Robert Smith
Director
Suren Dutia
Director

Shareholders

Name
Position
Leonard Mazur
Chairman and Chief Executive Officer and Director
Jaime Bartushak
Chief Financial Officer and Treasurer
Myron Holubiak
Director and Secretary
Myron S. Czuczman
Chief Medical Officer